Alecta Tjanstepension Omsesidigt’s ResMed RMD Stock Holding History

Alecta Tjanstepension Omsesidigt’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-494,998	Closed	-$98M	–	41
2024 Q1	$98M	Hold	494,998	–	–	0.56%	35
2023 Q4	$85.1M	Hold	494,998	–	–	0.53%	37
2023 Q3	$73.2M	Hold	494,998	–	–	0.55%	26
2023 Q2	$108M	Hold	494,998	–	–	0.78%	21
2023 Q1	$108M	Hold	494,998	–	–	0.68%	22
2022 Q4	$103M	Hold	494,998	–	–	0.61%	26
2022 Q3	$108M	Sell	494,998 -64,997	-12%	-$14.8M	0.66%	26
2022 Q2	$118M	Hold	559,995	–	–	0.68%	27
2022 Q1	$136M	Buy	559,995 +430,000	+331%	+$104M	0.66%	27
2021 Q4	$34.1M	Hold	129,995	–	–	0.15%	34
2021 Q3	$34.3M	Hold	129,995	–	–	0.16%	34
2021 Q2	$32M	Hold	129,995	–	–	0.15%	36
2021 Q1	$25.2M	Buy	129,995 +65,000	+100%	+$13M	0.13%	38
2020 Q4	$13.6M	Buy	+64,995	New	+$13M	0.08%	39

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt's RMD Position: Q2 2024 in Review

Alecta Tjanstepension Omsesidigt sold out of ResMed (RMD) in Q2 2024, closing a stake of 494,998 shares — an estimated $98M sold.

Alecta Tjanstepension Omsesidigt first reported a position in RMD in Q4 2020 and held it in 14 quarters. The position peaked at $136M in Q1 2022. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

Alecta Tjanstepension Omsesidigt reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
Alecta Tjanstepension Omsesidigt sold 494,998 ResMed shares in Q2 2024, an estimated $98M.
Alecta Tjanstepension Omsesidigt first reported a position in ResMed in Q4 2020 and held it in 14 quarters.
Alecta Tjanstepension Omsesidigt's ResMed position peaked at $136M in Q1 2022.
771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Alecta Tjanstepension Omsesidigt's 13F filing for Q2 2024, filed 31 Jul 2024.